Christopher Hanson

Strategic Advisor @Trio Pharmaceuticals, Inc

Mountain View, CA, US
MOBILE NUMBERS
+16•••••••00

Signup · Get unlimited contacts

WORK HISTORY

Oct 2019 — Present

Strategic Advisor @Trio Pharmaceuticals, Inc

View department →

San Diego, CA, US

TRIO Pharmaceuticals, Inc. is the ONLY company eradicating cancer by enhancing anti- tumor immunity. TRIO is doing that by proprietary dual targeting antibody drugs that in addition to killing cancer cells also kills immunosuppressor cells, thereby eliminating immunosuppression from the tumor and also, thereby allowing the body\'s immune system to launch an effective anti- tumor immune attack. TRIO\'s technology is validated in cell and animal models.

EDUCATION

1986 — 1990

Stanford University

Bachelor's degree, Slavic and Applied Linguistics

1986 — 1990

Stanford University

Master's degree, International Relations at CREES, Center for Russian and East European Studies

SKILLS

AnalyticsEntrepreneurshipR&DEnterprise SoftwareProduct MarketingGenomicsHigh Performance ComputingSaasSimulationsSoftware DevelopmentNanotechnologyProtein ExpressionStrategic PartnershipsDigital BiologyBig Data AnalyticsTeam LeadershipFragrancesComputer SecurityProteomicsTeam BuildingNew Venture CreationVenture CapitalBiotechnologyCodon OptimizationOlfactorySynthetic BiologyCompetitive AnalysisStart-UpsCyber SecurityGo-to-Market StrategyExecutive ManagementCloud ComputingProduct ManagementOlfactionFragranceVisual AnalyticsSoftware as a Service (Saas)Business DevelopmentVon Neumann ArchitectureCryptography

ABOUT CHRISTOPHER HANSON

Food is information. The right molecules, hitting the right receptors, tell the body how to regulate metabolism and control appetite.I work in receptor biology, AI-guided discovery, and getting formulations from bench to product. Can food-derived molecules activate olfactory and taste receptors located in the GI tract — known as ectopic receptors — to prompt the body to secrete its own GLP-1, GIP, and PYY hormones naturally, as part of its normal satiety signaling process? And get the same benefits as GLP-1 drugs, without the injections, the prescriptions, the synthetic chemistry?TruePath® is our attempt to answer that seriously. We screen 450+ ectopic chemosensory receptor types against more than food-derived compounds, and optimize multi-ligand combinations into formulations we can patent and reproduce. Not correlations—but mechanism-of-action data, at the receptor level.First product out of that platform is Pivit®: a $99/month OTC weight-loss supplement. Third-party medically supervised study, 12 weeks:~12 lbs average weight loss, 110% improvement in glucose stability (p=0.047).Food is information. Food is biological code.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.